NEW YORK (GenomeWeb News) - Denator of Gothenburg, Sweden, said yesterday that the Leiden University Medical Center has become an early-access customer for its tissue stabilization technology.
Researchers in the Dutch medical center’s department of parasitology and biomolecular mass spectrometry unit have purchased a Denator instrument, which is scheduled for commercial launch at the annual Human Proteome Organization meeting in August.
A Denator spokeswoman said that the agreement grew out of a collaboration between the medical center and the company that has been in place “for a period of time.”
André Deelder, head of the department of parasitology at the medical center, said in a statement that protein degradation can “interfere significantly” with proteomics experiments, particularly in the case of snap-frozen samples, in which “the risk of further degradation returns when samples need to be thawed.”
Deelder added that “preliminary results indicate that Denator’s rapid heat inactivation technology stabilizes tissues instantly and this stability is maintained during downstream analyses.”
Financial terms of the agreement were not disclosed.